-
Quest Diagnostics is selling a blood test online to consumers. But results may not be reliable or easy to interpret. And it isn’t covered by insurance.
-
The FDA had been expected to decide by next week, but a back-and-forth between state and federal officials about details of the proposal means the wait will continue, a court document says.
-
The drug store chain said it will remove a small number of oral decongestants that contain phenylephrine as the only active ingredient.
-
Most contain added sugar and are targeted toward children who are at the age when they could develop a lasting taste for sweets, possibly leading to obesity and other diseases.
-
Hair stylists say Black women have largely moved away from chemical straighteners and smoothers because of the potential health risks.
-
In a torrent of lawsuits in Alachua County, patients accuse device maker Exactech of hiding knee and hip implant defects for years. The company denies the allegations.
-
The FDA panel voted 17-1 that drugmaker Brainstorm’s stem cell-based treatment has not been shown effective for patients with amyotrophic lateral sclerosis. One panel member abstained from voting.
-
The agency reiterated its longstanding position that a lone study by drugmaker Brainstorm doesn't provide convincing evidence that its stem cell-based therapy helps patients with amyotrophic lateral sclerosis.
-
The FDA told the manufacturer to conduct another study on epinephrine spray, which halts potentially life-threating allergic reactions called anaphylaxis.
-
Days after the CDC recommended a broad rollout of the vaccine, state Surgeon General Dr. Joseph Ladapo issued guidance that recommended against individuals under 65 from taking the shot.